CAI peer analysis
Caris Life Sciences (CAI) against its competitors: price, today's move, 1-year return and market value side by side.
CAI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADPT Adaptive Bio | $25.04 | -6.01% | 48.08% | $4.25B |
| BIAF bioAffinity | $2.95 | 1.37% | -91.94% | – |
| CSTL Castle Biosciences | $34.95 | -5.95% | 44.36% | $1.14B |
| IMDX Insight Molecular Diagnostics | $2.96 | -6.92% | -50.04% | – |
| NEO NeoGenomics | $16.49 | -5.12% | 70.18% | $2.25B |
| PSNL Personalis | $15.77 | -0.32% | 65.83% | $1.69B |
| WGS GeneDx | $64.11 | -7.17% | -51.25% | $2.06B |
| CAI Caris Life Sciences | $32.10 | -6.48% | 3.00% | $9.70B |
- CAI's peers: ADPT (Adaptive Bio), BIAF (bioAffinity), CSTL (Castle Biosciences), IMDX (Insight Molecular Diagnostics), NEO (NeoGenomics), PSNL (Personalis), WGS (GeneDx).
Updated 2026-11-03 00:14 UTC